用网约车思维解决患者招募行业痛点 智募云打造多方共赢的生态正循环

Core Insights - The article discusses the challenges in patient recruitment for clinical trials and how Jiangsu Zhimuyun Technology Co., Ltd. (Zhimuyun) is addressing these issues through an innovative platform model [1][2] - Zhimuyun aims to create a "positive ecological cycle" in the industry, ensuring that all parties involved in patient recruitment benefit, thereby promoting sustainable development [2][5] Company Overview - Zhimuyun has been established for two years and has quickly gained attention in the industry due to its unique platform model that integrates the recruitment needs of pharmaceutical companies with patient resource holders [1][2] - The platform operates similarly to ride-hailing services, matching pharmaceutical companies' recruitment demands with various partners who have access to patient resources, such as grassroots hospitals and physician groups [2] Recruitment Model - The recruitment model focuses on three main aspects: assessment, empowerment, and service [3] - Assessment involves a scientific evaluation of the potential benefits for patients participating in trials, ensuring informed decision-making [3] - Empowerment emphasizes transparency, using simple language to explain trial processes, risks, and rights to patients [3] - Service provides dedicated medical advisors to assist patients throughout the recruitment process, ensuring safety and convenience [3] Digital Platform Benefits - Zhimuyun's digital platform enhances pharmaceutical companies' operations across three dimensions: broad coverage, high efficiency, and low risk [4] - Broad coverage is achieved by integrating over 3,000 medical institutions and more than 3 million patient data points, particularly focusing on grassroots and community-level coverage [4] - High efficiency is realized through an AI system that quickly matches patient characteristics with trial requirements, significantly improving recruitment speed [4] - Low risk is ensured by maintaining compliance and traceability of patient information, which helps reduce regulatory risks and costs for pharmaceutical companies [4] Future Industry Impact - Zhimuyun envisions that its "positive cycle" model will lead to a more standardized and efficient clinical research process, fostering a healthier and more sustainable future for the industry [5]